ライフサイエンスコーパス: impaired cognition

1 to positive and negative symptoms as well as impaired cognition.

2 lf-care, even in heart failure patients with impaired cognition.

3 eart failure self-care even in patients with impaired cognition.

4 y, but only male offspring of this group had impaired cognition.

5 idence and time of conversion from normal to impaired cognition.

6 eatment response in diseases associated with impaired cognition.

7 changes in net synaptic efficacy, leading to impaired cognition.

8 uld lead to defective cortical circuitry and impaired cognition.

9 ilure care, is challenging for patients with impaired cognition.

10 hat Bcl11a haploinsufficiency in mice causes impaired cognition, abnormal social behavior, and microc

11 f PD, including disrupted visual perception, impaired cognition across a range of domains, and psychi

12 ric acid (GABA) deficits have been linked to impaired cognition and addictive disorders, we hypothesi

13 ic input to the cortex likely contributes to impaired cognition and behavior.

14 in part have a microvascular origin such as impaired cognition and heart failure.

15 deficits lead to poor functional outcome via impaired cognition and increased negative symptoms.

16 hol during the brain growth spurt results in impaired cognition and learning in adulthood.

17 tings, and with a novel clinical syndrome of impaired cognition and memory disturbance among humans a

18 ta) peptides in the brain is associated with impaired cognition and memory, pronounced inflammatory d

19 fects ranging from anaemia, growth stunting, impaired cognition, and decreased physical fitness, to o

20 e reduced ERK2 levels, exhibit microcephaly, impaired cognition, and developmental delay.

21 to be male and to have low body mass index, impaired cognition, and microalbuminuria.

22 ar defects associated with the initiation of impaired cognition are poorly characterized.

23 rrelations between high circulating AGEs and impaired cognition, as well as insulin sensitivity in ol

24 matter microstructure that may underlie the impaired cognition characteristic of this CNV.

25 Syndromes 1 ("impaired cognition," characterized by problems with atte

26 isorders of CP are frequently accompanied by impaired cognition, communication, and sensory perceptio

27 Syndromes 1-3 are described as "impaired cognition," "confusion-ataxia," and "central pa

28 to the ICU were old (87.7 +/- 5.4 yrs) with impaired cognition (CPS 2.8 +/- 1.7, range 0-6, where 6

29 s, decreased activities of daily living, and impaired cognition did not consistently predict falls ac

30 Cannabis use has been associated with impaired cognition during acute intoxication as well as

31 characterized decline in NMDAR function and impaired cognition during aging.

32 the fragile X mouse, mechanisms relevant to impaired cognition in fragile X syndrome.

33 Mouse genetic models of DS exhibit impaired cognition in hippocampally mediated behavioral

34 isabling disorganization symptoms related to impaired cognition in individuals with schizophrenia.

35 disease, but it also confers major risk for impaired cognition in normal aging or Alzheimer's diseas

36 contribute to altered gamma-oscillations and impaired cognition in schizophrenia.

37 asis for altered cortical GABA synthesis and impaired cognition in schizophrenia.

38 used to evaluate brain substrates underlying impaired cognition in schizophrenia.

39 rsolateral prefrontal cortex dysfunction and impaired cognition in schizophrenia.

40 nks between specific brain abnormalities and impaired cognition in these conditions, research using n

41 ibitors for treatment of disorders involving impaired cognition, including Alzheimer's disease.

42 elated potassium channel, is associated with impaired cognition, inefficient neural processing and sc

43 Impaired cognition is a recognized characteristic of the

44 rs is the long-term disability that involves impaired cognition, lack of social support, and an inabi

45 p, myelodysplastic syndrome, and hemoglobin, impaired cognition (Modified Mini-Mental State Exam < 77

46 rkers related to 6-month mortality included: impaired cognition (P < 0.01), recent falls (P < 0.01),

47 in schizophrenia, a disorder associated with impaired cognition, p35 expression is reduced in relevan

48 the precise molecular mechanisms underlying impaired cognition remain unclear.

49 tle evidence for cell death, suggesting that impaired cognition results from a cellular or synaptic d

50 of testosterone replacement in patients with impaired cognition, such as people with Alzheimer's dise

51 in three Gulf War illness groups-syndrome 1 (impaired cognition), syndrome 2 (confusion-ataxia), and

52 with alcoholic liver disease (ALD) have more impaired cognition than nonalcoholics.

53 Impaired cognition was significantly associated with low

54 Risk of syndrome 1 ("impaired cognition") was greater in veterans who reporte

55 Cases (n=5) with syndrome 1 ("impaired cognition") were the most impaired on brain ste